Cargando…
Closed Gateways — Can Neuroprotectants Shield the Retina in Glaucoma?
Neuroprotection for glaucoma is a therapeutic approach that aims to prevent optic nerve damage or cell death. An appropriate drug that reaches an adequate concentration across the blood retinal barrier is expected to shield the retina in glaucoma. Several in vitro and in vivo attempts in experimenta...
Autor principal: | Velpandian, Thirumurthy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585762/ https://www.ncbi.nlm.nih.gov/pubmed/20698718 http://dx.doi.org/10.2165/11539310-000000000-00000 |
Ejemplares similares
-
Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
por: Nath, Madhu, et al.
Publicado: (2017) -
A Coming of Age for Glaucoma Neuroprotection
por: Johnson, Thomas V.
Publicado: (2023) -
Novel Insight of Histamine and Its Receptor Ligands in Glaucoma and Retina Neuroprotection
por: Sgambellone, Silvia, et al.
Publicado: (2021) -
Elevated histamine levels in aqueous humor of patients with glaucoma
por: Gowtham, Lakshminarayanan, et al.
Publicado: (2021) -
Therapeutic potential of valproic acid in advanced glaucoma: A pilot study
por: Mahalingam, Karthikeyan, et al.
Publicado: (2018)